Pharsight Monthly Summary
FEBRUARY, 2023
Recent happenings in patent protected drugs.
spacer_11
At a Glance
283
drug patents lapsed
Photos
94
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
AMGEN INC
 
AMYLYX
 
AXSOME MALTA
 
AZURITY
 
BEONE MEDICINES USA
 
BOEHRINGER INGELHEIM
 
BRISTOL
 
CMP DEV LLC
 
DECIPHERA PHARMS
 
EISAI INC
 
GENENTECH INC
 
GLAXOSMITHKLINE
 
HELSINN HLTHCARE
 
INCYTE CORP
 
JANSSEN BIOTECH
 
LOXO ONCOL
 
MEDICINES360
 
NEXUS
 
NORTON WATERFORD
 
NOVARTIS
 
NOVEN PHARMS INC
 
OPTINOSE US INC
 
STEMLINE THERAP
 
TEVA
 
TEVA BRANDED PHARM
 
TEVA PHARM
 
THERACOSBIO
 
TOLMAR
 
TRIS PHARMA INC
 
VANDA PHARMS INC
 
VERITY
 
VERTEX PHARMS
 
VERTEX PHARMS INC
 
ZMI PHARMA
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE ALEXZA PHARMS
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ARNUITY ELLIPTA GLAXOSMITHKLINE
AXUMIN BLUE EARTH
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN NOVO
MYRBETRIQ GRANULES APGDI
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
ORBACTIV MELINTA THERAP
RAPIVAB BIOCRYST
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VENLAFAXINE BESYLATE ALMATICA
VIIBRYD ABBVIE
VYVANSE TAKEDA PHARMS USA
XEPI FERRER INTERNACIONAL
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
CHANTIX 7265119*PED Feb, 2023
CHANTIX 7265119*PED Feb, 2023
DALIRESP 8431154 Feb, 2023
DALIRESP 9468598 Feb, 2023
DALIRESP 8431154 Feb, 2023
DALIRESP 9468598 Feb, 2023
DEXILANT SOLUTAB 6664276 Jan, 2023
KYNMOBI 8663687 Feb, 2023
KYNMOBI 8663687 Feb, 2023
KYNMOBI 8663687 Feb, 2023
KYNMOBI 8663687 Feb, 2023
KYNMOBI 8663687 Feb, 2023
LEQVIO 8232383 Feb, 2023
LEXAPRO 6916941*PED Feb, 2023
LEXAPRO 7420069*PED Feb, 2023
LEXAPRO 6916941*PED Feb, 2023
LEXAPRO 7420069*PED Feb, 2023
LEXAPRO 6916941*PED Feb, 2023
LEXAPRO 7420069*PED Feb, 2023
NEXAVAR 8618141 Feb, 2023
OPANA ER 7276250 Feb, 2023
OPANA ER 8309112 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 7276250 Feb, 2023
OPANA ER 8309112 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 7276250 Feb, 2023
OPANA ER 8309112 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 7276250 Feb, 2023
OPANA ER 8309112 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 7276250 Feb, 2023
OPANA ER 8309112 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 7276250 Feb, 2023
OPANA ER 8309112 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 7276250 Feb, 2023
OPANA ER 8309112 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 8309122 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 8309122 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 8309122 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 8309122 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 8309122 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 8309122 Feb, 2023
OPANA ER 8329216 Feb, 2023
OPANA ER 8309122 Feb, 2023
OPANA ER 8329216 Feb, 2023
PATANASE 7977376 Feb, 2023
RYANODEX 8685460 Feb, 2023
SAXENDA 6268343*PED Feb, 2023
SUBOXONE 8017150 Feb, 2023
SUBOXONE 8017150 Feb, 2023
SUBOXONE 8017150 Feb, 2023
SUBOXONE 8017150 Feb, 2023
SYMBICORT 10166247 Jan, 2023
SYMBICORT 11311558 Jan, 2023
SYMBICORT 7759328 Jan, 2023
SYMBICORT 8143239 Jan, 2023
SYMBICORT 8575137 Jan, 2023
SYMBICORT 10166247 Jan, 2023
SYMBICORT 11311558 Jan, 2023
SYMBICORT 7759328 Jan, 2023
SYMBICORT 8143239 Jan, 2023
SYMBICORT 8575137 Jan, 2023
TEMODAR 7786118 Feb, 2023
TEMODAR 8623868 Feb, 2023
TRICOR 7276249 Feb, 2023
TRICOR 7320802 Feb, 2023
TRICOR 7276249 Feb, 2023
TRICOR 7320802 Feb, 2023
VICTOZA 6268343*PED Feb, 2023
VIMOVO 6926907 Feb, 2023
VIMOVO 6926907 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7223735 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7674774 Feb, 2023
VYVANSE 7678770 Feb, 2023
VYVANSE 7678771 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7687467 Feb, 2023
VYVANSE 7700561 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7105486 Feb, 2023
VYVANSE 7223735 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7674774 Feb, 2023
VYVANSE 7678770 Feb, 2023
VYVANSE 7678771 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7687467 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7105486 Feb, 2023
VYVANSE 7223735 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7674774 Feb, 2023
VYVANSE 7678770 Feb, 2023
VYVANSE 7678771 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7687467 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7105486 Feb, 2023
VYVANSE 7223735 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7674774 Feb, 2023
VYVANSE 7678770 Feb, 2023
VYVANSE 7678771 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7687467 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7105486 Feb, 2023
VYVANSE 7223735 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7674774 Feb, 2023
VYVANSE 7678770 Feb, 2023
VYVANSE 7678771 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7687467 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7105486 Feb, 2023
VYVANSE 7223735 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7674774 Feb, 2023
VYVANSE 7678770 Feb, 2023
VYVANSE 7678771 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7687467 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
VYVANSE 7105486 Feb, 2023
VYVANSE 7223735 Feb, 2023
VYVANSE 7655630 Feb, 2023
VYVANSE 7659253 Feb, 2023
VYVANSE 7659254 Feb, 2023
VYVANSE 7662787 Feb, 2023
VYVANSE 7662788 Feb, 2023
VYVANSE 7671030 Feb, 2023
VYVANSE 7671031 Feb, 2023
VYVANSE 7674774 Feb, 2023
VYVANSE 7678770 Feb, 2023
VYVANSE 7678771 Feb, 2023
VYVANSE 7687466 Feb, 2023
VYVANSE 7687467 Feb, 2023
VYVANSE 7713936 Feb, 2023
VYVANSE 7718619 Feb, 2023
VYVANSE 7723305 Feb, 2023
XULTOPHY 100/3.6 6268343*PED Feb, 2023
YOSPRALA 6926907 Feb, 2023
YOSPRALA 8206741 Feb, 2023
YOSPRALA 6926907 Feb, 2023
YOSPRALA 8206741 Feb, 2023
ZECUITY 6745071 Feb, 2023
ZERIT XR 7135465 Feb, 2023
ZERIT XR 7135465 Feb, 2023
ZERIT XR 7135465 Feb, 2023
ZERIT XR 7135465 Feb, 2023
ZYKADIA 8188276 Jan, 2023
ZYKADIA 8835430 Jan, 2023
ZYKADIA 9018204 Jan, 2023
ZYKADIA 9416112 Jan, 2023
ZYKADIA 8188276 Jan, 2023
ZYKADIA 8835430 Jan, 2023
ZYKADIA 9018204 Jan, 2023
ZYKADIA 9416112 Jan, 2023
Newly introduced Drug Patents
Drug Patent Patent expiry
AKYNZEO 11559523 Nov, 2030
ARMONAIR DIGIHALER 11357935*PED Mar, 2039
ARMONAIR DIGIHALER 11439777*PED Nov, 2040
ARMONAIR DIGIHALER 11464923*PED Dec, 2040
ATORVALIQ 11369567 Jun, 2037
AUSTEDO 11564917 Mar, 2036
AUSTEDO XR 10959996 Mar, 2036
AUSTEDO XR 11179386 Mar, 2038
AUSTEDO XR 11311488 Jun, 2041
AUSTEDO XR 11357772 Mar, 2036
AUSTEDO XR 11446291 Mar, 2036
AUSTEDO XR 11564917 Mar, 2036
AUSTEDO XR 8524733 Apr, 2031
AUSTEDO XR 9550780 Sep, 2033
BRENZAVVY 10533032 Jul, 2031
BRENZAVVY 10981942 Jun, 2031
BRENZAVVY 7838499 Jan, 2029
BRENZAVVY 8106021 Aug, 2028
BRENZAVVY 8802637 Aug, 2028
BRENZAVVY 8987323 May, 2032
BRUKINSA 11591340 Aug, 2037
DYANAVEL XR 11590228 Sep, 2036
DYANAVEL XR 10 11590081 Sep, 2038
DYANAVEL XR 15 11590081 Sep, 2038
DYANAVEL XR 20 11590081 Sep, 2038
DYANAVEL XR 5 11590081 Sep, 2038
EMERPHED 11571398 May, 2040
ERLEADA 10702508 Apr, 2038
ERLEADA 10849888 Sep, 2033
ERLEADA 8445507 Sep, 2030
ERLEADA 8802689 Mar, 2027
ERLEADA 9388159 Mar, 2027
ERLEADA 9481663 Jun, 2033
ERLEADA 9884054 Sep, 2033
ERLEADA 9987261 Mar, 2027
ERLEADA RE49353 Sep, 2033
EVRYSDI 11534444 Oct, 2038
HETLIOZ 11566011 Feb, 2035
HETLIOZ LQ 11566011 Feb, 2035
JATENZO 11564933 Apr, 2039
JAYPIRCA 10342780 Dec, 2036
JAYPIRCA 10464905 Dec, 2036
JAYPIRCA 10695323 Dec, 2036
JAYPIRCA 10918622 Dec, 2036
JESDUVROQ 11117871 Mar, 2038
JESDUVROQ 8324208 Dec, 2028
JESDUVROQ 8557834 Jun, 2027
JESDUVROQ 8815884 Jun, 2027
KALYDECO 11564916 Aug, 2029
KALYDECO 11564916 Aug, 2029
LENVIMA 11090386 Feb, 2036
LILETTA 11571328 Sep, 2040
LUMAKRAS 10519146 May, 2038
LUMAKRAS 11236091 May, 2040
LUMAKRAS 11426404 Sep, 2040
MEKINIST 10869869*PED Feb, 2034
MEKINIST 7378423*PED Nov, 2027
MEKINIST 8580304*PED Jul, 2032
MEKINIST 8703781*PED Apr, 2031
MEKINIST 8835443*PED Dec, 2025
MEKINIST 8952018*PED Apr, 2031
MEKINIST 9155706*PED Jul, 2032
MEKINIST 9271941*PED Jul, 2032
MEKINIST 9399021*PED Jul, 2032
ONUREG 11571436 May, 2029
OPZELURA 11571425 May, 2031
ORKAMBI 11564916 Aug, 2029
ORSERDU 10071066 Oct, 2034
ORSERDU 10745343 Jan, 2038
ORSERDU 8399520 Dec, 2025
PREVDUO 10456354 Oct, 2038
PREVDUO 11110054 Oct, 2038
QINLOCK 11576903 Dec, 2040
QINLOCK 11576904 Aug, 2040
QVAR REDIHALER 11559637 Jul, 2039
RELYVRIO 11583542 Jul, 2040
SUNOSI 11160779 Mar, 2040
SUNOSI 11560354 Mar, 2039
SYMDEKO (COPACKAGED) 11564916 Aug, 2029
SYNJARDY 9949997 May, 2034
SYNJARDY XR 9949997 May, 2034
TAFINLAR 10869869*PED Feb, 2034
TAFINLAR 7994185*PED Jul, 2030
TAFINLAR 8415345*PED Jul, 2030
TAFINLAR 8703781*PED Apr, 2031
TAFINLAR 8835443*PED Dec, 2025
TAFINLAR 8952018*PED Apr, 2031
TAFINLAR 9233956*PED Nov, 2029
TLANDO 11559530 Nov, 2037
TRIJARDY XR 11564886 Mar, 2032
TRIKAFTA (COPACKAGED) 11564916 Aug, 2029
XELSTRYM 11559501 Jan, 2042
XHANCE 11554229 Feb, 2036
ZIMHI 11571518 Jun, 2041
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2023 GreyB Research